Cargando…

Low-dose temozolomide before dendritic-cell vaccination reduces (specifically) CD4(+)CD25(++)Foxp3(+) regulatory T-cells in advanced melanoma patients

BACKGROUND: In cancer immunotherapy, dendritic cells (DCs) play a fundamental role in the dialog between innate and adaptive immune response, but several immunosuppressive mechanisms remain to be overcome. For example, a high number of CD4(+)CD25(++)Foxp3(+) regulatory T-cells (Foxp3+Tregs) have bee...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ridolfi, Laura, Petrini, Massimiliano, Granato, Anna Maria, Gentilcore, Giusy, Simeone, Ester, Ascierto, Paolo Antonio, Pancisi, Elena, Ancarani, Valentina, Fiammenghi, Laura, Guidoboni, Massimo, de Rosa, Francesco, Valmorri, Linda, Scarpi, Emanuela, Nicoletti, Stefania Vittoria Luisa, Baravelli, Stefano, Riccobon, Angela, Ridolfi, Ruggero
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3698134/ https://www.ncbi.nlm.nih.gov/pubmed/23725550 http://dx.doi.org/10.1186/1479-5876-11-135

Ejemplares similares

Erratum to “Unexpected High Response Rate to Traditional Therapy after Dendritic Cell-Based Vaccine in Advanced Melanoma: Update of Clinical Outcome and Subgroup Analysis”
por: Ridolfi, Laura, et al.
Publicado: (2011)

Unexpected High Response Rate to Traditional Therapy after Dendritic Cell-Based Vaccine in Advanced Melanoma: Update of Clinical Outcome and Subgroup Analysis
por: Ridolfi, Laura, et al.
Publicado: (2010)

FRET microscopy autologous tumor lysate processing in mature dendritic cell vaccine therapy
por: Fiammenghi, Laura, et al.
Publicado: (2010)

Vaccination with autologous dendritic cells loaded with autologous tumor lysate or homogenate combined with immunomodulating radiotherapy and/or preleukapheresis IFN-α in patients with metastatic melanoma: a randomised “proof-of-principle” phase II study
por: de Rosa, Francesco, et al.
Publicado: (2014)

Complementary vaccination protocol with dendritic cells pulsed with autologous tumour lysate in patients with resected stage III or IV melanoma: protocol for a phase II randomised trial (ACDC Adjuvant Trial)
por: Ridolfi, Laura, et al.
Publicado: (2018)

Improved overall survival in dendritic cell vaccination-induced immunoreactive subgroup of advanced melanoma patients
por: Ridolfi, Ruggero, et al.
Publicado: (2006)

Radiotherapy as an immunological booster in patients with metastatic melanoma or renal cell carcinoma treated with high-dose Interleukin-2: evaluation of biomarkers of immunologic and therapeutic response
por: Ridolfi, Laura, et al.
Publicado: (2014)

Evaluation of in vivo labelled dendritic cell migration in cancer patients
por: Ridolfi, Ruggero, et al.
Publicado: (2004)

Radiotherapy and High-Dose Interleukin-2: Clinical and Immunological Results of a Proof of Principle Study in Metastatic Melanoma and Renal Cell Carcinoma
por: Bulgarelli, Jenny, et al.
Publicado: (2021)

Dendritic Cell Vaccination in Metastatic Melanoma Turns “Non-T Cell Inflamed” Into “T-Cell Inflamed” Tumors
por: Bulgarelli, Jenny, et al.
Publicado: (2019)

Stability Program in Dendritic Cell Vaccines: A “Real-World” Experience in the Immuno-Gene Therapy Factory of Romagna Cancer Center
por: Pancisi, Elena, et al.
Publicado: (2022)

The Renewal of Cancer Immunotherapy
por: Bulgarelli, Jenny, et al.
Publicado: (2023)

Restored T-cell activation mechanisms in human tumour-infiltrating lymphocytes from melanomas and colorectal carcinomas after exposure to interleukin-2
por: De Paola, F, et al.
Publicado: (2003)

Biomonitoring of Metals in Children Living in an Urban Area and Close to Waste Incinerators
por: Di Ciaula, Agostino, et al.
Publicado: (2020)

Central nervous system failure in melanoma patients: results of a randomised, multicentre phase 3 study of temozolomide- and dacarbazine- based regimens
por: Chiarion-Sileni, V, et al.
Publicado: (2011)

Androgen receptor modulates Foxp3 expression in CD4(+)CD25(+)Foxp3(+) regulatory T-cells
por: Walecki, Magdalena, et al.
Publicado: (2015)

The control of CD4(+)CD25(+)Foxp3(+ )regulatory T cell survival
por: Pandiyan, Pushpa, et al.
Publicado: (2008)

Identity of mysterious CD4(+)CD25(-)Foxp3(+ )cells in SLE
por: Horwitz, David A
Publicado: (2010)

NF-κB as potential target in the treatment of melanoma
por: Madonna, Gabriele, et al.
Publicado: (2012)

Blockade of TGF-β signaling to enhance the antitumor response is accompanied by dysregulation of the functional activity of CD4(+)CD25(+)Foxp3(+) and CD4(+)CD25(−)Foxp3(+) T cells
por: Polanczyk, Magdalena J., et al.
Publicado: (2019)

The Ratios of CD8(+) T Cells to CD4(+)CD25(+) FOXP3(+) and FOXP3(-) T Cells Correlate with Poor Clinical Outcome in Human Serous Ovarian Cancer
por: Preston, Claudia C., et al.
Publicado: (2013)

All-Trans Retinoic Acid Induces CD4+CD25+FOXP3+ Regulatory T Cells by Increasing FOXP3 Demethylation in Systemic Sclerosis CD4+ T Cells
por: Sun, Xiaohong, et al.
Publicado: (2018)

Alteration of CD4(+)CD25(+)Foxp3(+) T cell level in Kawasaki disease
por: Sohn, Su Ye, et al.
Publicado: (2011)

CD4(+)CD25(-)Foxp3(+) T cells: a marker for lupus nephritis?
por: Bonelli, Michael, et al.
Publicado: (2014)

Presence of Foxp3-expressing CD19(+)CD5(+) B Cells in Human Peripheral Blood Mononuclear Cells: Human CD19(+)CD5(+)Foxp3(+) Regulatory B Cell (Breg)
por: Noh, Joonyong, et al.
Publicado: (2010)

Promiscuous Foxp3-cre activity reveals a differential requirement for CD28 in Foxp3(+) and Foxp3(−) T cells
por: Franckaert, Dean, et al.
Publicado: (2015)

Numerical status of CD4(+)CD25(+)FoxP3(+) and CD8(+)CD28(-) regulatory T cells in multiple sclerosis
por: Kouchaki, Ebrahim, et al.
Publicado: (2014)

Potency Assessment of Dendritic Cell Anticancer Vaccine: Validation of the Co-Flow DC Assay
por: Carloni, Silvia, et al.
Publicado: (2021)

Ipilimumab treatment decreases circulating Tregs and GrMDSC while enhancing CD4+ T cell activation
por: Pico de Coaña, Yago, et al.
Publicado: (2015)

Efficacy and safety of ipilimumab in patients with advanced melanoma and brain metastases
por: Queirolo, Paola, et al.
Publicado: (2014)

CD3(+), CD8(+), CD4(+) and FOXP3(+) T Cells in the Immune Microenvironment of Small Bowel Neuroendocrine Tumors
por: Hiltunen, Niko, et al.
Publicado: (2021)

Mesangiogenic Progenitor Cells Derived from One Novel CD64(bright)CD31(bright)CD14(neg) Population in Human Adult Bone Marrow
por: Pacini, Simone, et al.
Publicado: (2016)

Increased numbers of CD5(+)CD19(+)CD1d(high)IL-10(+) Bregs, CD4(+)Foxp3(+) Tregs, CD4(+)CXCR5(+)Foxp3(+) follicular regulatory T (TFR) cells in CHB or CHC patients
por: Wang, Li, et al.
Publicado: (2014)

CD4(+)CD25(high)FoxP3(+) Regulatory T-cells in Hematologic Diseases
por: Moon, Hee-Won, et al.
Publicado: (2011)

56 Increased Frequency of CD4+ CD25+ FOXP3- in Allergic Conjunctivitis Patients
por: Galicia-Carreón, Jorge, et al.
Publicado: (2012)

Changes in Natural Foxp3(+)Treg but Not Mucosally-Imprinted CD62L(neg)CD38(+)Foxp3(+)Treg in the Circulation of Celiac Disease Patients
por: van Leeuwen, Marieke A., et al.
Publicado: (2013)

Correlation of CD8+ Expression, Foxp3+ Expression, and CD8+/Foxp3+ Ratio with Triple Negative Breast Cancer Stage in Sanglah General Hospital
por: Sudarsa, I Wayan, et al.
Publicado: (2019)

Effect of dabrafenib on melanoma cell lines harbouring the BRAF(V600D/R) mutations
por: Gentilcore, Giusy, et al.
Publicado: (2013)

Human Umbilical Vein Endothelial Cells foster conversion of CD4(+)CD25(−)Foxp3(−) T cells into CD4(+)Foxp3(+) Regulatory T Cells via Transforming Growth Factor-β
por: Oettel, Anika, et al.
Publicado: (2016)

Hepatitis B envelope antigen increases Tregs by converting CD4+CD25(-) T cells into CD4(+)CD25(+)Foxp3(+) Tregs
por: Tang, Rui, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_l6qg8amldbl7i3q2cmg7ifv7sk